Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL.
City of Hope Medical Center
City of Hope Medical Center
Amgen
Celldex Therapeutics
Seagen Inc.
Novartis
Merck Sharp & Dohme LLC
University of Washington
Royal Marsden NHS Foundation Trust
Ohio State University Comprehensive Cancer Center